Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/232227 
Year of Publication: 
2020
Series/Report no.: 
Research Paper No. 107
Publisher: 
South Centre, Geneva
Abstract: 
Like other rights, patent rights are not absolute. There are situations in which their exercise can be limited to protect public interests. Such situations may arise, for instance, when access to needed pharmaceutical products must be ensured. Compulsory licenses and government use for non-commercial purposes are tools, provided for under most laws worldwide, that can specifically be used to address public health needs. This document is intended to provide legal guidance for the effective use of such tools, consistently with the international law.
Subjects: 
Access to Medicines
Affordable Medicines
Compulsory Licenses
COVID-19
Data Exclusivity
Diagnostics
Doha Declaration on the TRIPS Agreement and Public Health
Evergreening
Flexibilities
Global Health
Government Use
Health
Innovation
Intellectual Property
Least Developed Countries (LDCs)
Patent
Pharmaceuticals
Public Health
Research and Development (R&D)
TRIPS
Vaccines
Voluntary License
WHO
WHO Global Strategy (GSPOA)
World Health Organization (WHO)
Document Type: 
Research Report
Appears in Collections:

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.